Alaunos Therapeutics Announces Executive Financial Leadership Changes
Alaunos Therapeutics Regains Nasdaq Listing Compliance
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
GainersCogent Biosciences (NASDAQ:COGT) shares rose 45.6% to $7.95 during Wednesday's pre-market session. The company's market cap stands at $684.6 million. Lineage Cell Therapeutics (AMEX:LCTX) stock
TCRT, NXT and MINM Among Mid-day Movers
Alaunos Therapeutics To Carry Out 1-for-15 Reverse Stock Split On February 1st, 2024
January 30th - $Alaunos Therapeutics(TCRT.US)$ is about to implement a 1-for-15 reverse stock split of shares. The shares will begin trading on a split-adjusted basis from February 1st, 2024.$Alaunos
Alaunos Therapeutics Appoints Dale Curtis Hogue As Interim CEO, Effective Jan. 20 2024; Hogue Will Continue Serving On The Board
Alaunos Therapeutics Appoints Dale Curtis Hogue As Interim CEO, Effective Jan. 20 2024; Hogue Will Continue Serving On The Board
12 Health Care Stocks Moving In Friday's Pre-Market Session
GainersMesoblast (NASDAQ:MESO) shares increased by 22.1% to $2.1 during Friday's pre-market session. The company's market cap stands at $180.2 million. Sangamo Therapeutics (NASDAQ:SGMO) stock rose 20
12 Health Care Stocks Moving In Monday's After-Market Session
GainersAkso Health Group (NASDAQ:AHG) stock increased by 23.4% to $1.32 during Monday's after-market session. The market value of their outstanding shares is at $30.1 million. Assure Hldgs (NASDAQ:ION
12 Health Care Stocks Moving In Friday's Intraday Session
GainersAinos (NASDAQ:AIMD) stock moved upwards by 74.0% to $3.01 during Friday's regular session. The market value of their outstanding shares is at $14.0 million. Elevation Oncology (NASDAQ:ELEV) sto
On December 22, 2023, Alaunos Therapeutics Entered Into Separation And Release Agreement With CEO Kevin Boyle In Connection With Boyle's Termination - Filing
The Company and Boyle also entered into a consulting agreement, effective January 1, 2024, pursuant to which Boyle will continue providing strategic and advisory services to the company. The Consultin
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
GainersBiomerica (NASDAQ:BMRA) shares rose 54.5% to $1.53 during Tuesday's pre-market session. The market value of their outstanding shares is at $25.7 million. Cingulate (NASDAQ:CING) stock increased
12 Health Care Stocks Moving In Monday's Pre-Market Session
GainersBiomerica (NASDAQ:BMRA) shares rose 71.7% to $1.7 during Monday's pre-market session. The market value of their outstanding shares is at $28.5 million. Arcutis Biotherapeutics (NASDAQ:ARQT) sha
12 Health Care Stocks Moving In Friday's After-Market Session
GainersMira Pharmaceuticals (NASDAQ:MIRA) shares moved upwards by 9.2% to $3.59 during Friday's after-market session. The market value of their outstanding shares is at $53.0 million. TC BioPharm (Hol
12 Health Care Stocks Moving In Wednesday's Intraday Session
GainersPaxMedica (NASDAQ:PXMD) shares rose 33.6% to $1.07 during Wednesday's regular session. The market value of their outstanding shares is at $1.1 million. Impel Pharmaceuticals (NASDAQ:IMPL) share
Recap: Alaunos Therapeutics Q3 Earnings
Alaunos Therapeutics (NASDAQ:TCRT) reported its Q3 earnings results on Tuesday, November 14, 2023 at 07:30 AM.Here's what investors need to know about the announcement.EarningsAlaunos Therapeutics mis
Alaunos Therapeutics Q3 EPS $(0.04), Same As Last Year
Alaunos Therapeutics (NASDAQ:TCRT) reported quarterly losses of $(0.04) per share. This is unchanged from the same period last year.
Press Release: Alaunos Therapeutics Announces Third Quarter 2023 Financial Results, Phase 1 Clinical Data and Continued Exploration of Strategic Alternatives
Alaunos Therapeutics Announces Third Quarter 2023 Financial Results, Phase 1 Clinical Data and Continued Exploration of Strategic Alternatives -- TCR-T Library Phase 1/2 trial achieved an 87% dise
Alaunos Therapeutics 3Q Loss/Shr 4c >TCRT
Alaunos Therapeutics 3Q Loss/Shr 4c >TCRT
Alaunos Therapeutics Inc. (TCRT): A Comprehensive Review of Recent Highlights and Pre-Market Movements
Alaunos Therapeutics Inc. (TCRT) is a name to remember in the world of T-cell receptor (TCR) cell therapy. With its unique hunTR (human neoantigen T-cell Receptor) discovery platform, the company has been making significant strides in the medical field. Nevertheless, it has experienced considerable market fluctuations of late. In this piece, we explore the recent ...
Alaunos Therapeutics Announces Third Quarter 2023 Financial Results, Phase 1 Clinical Data and Continued Exploration of Strategic Alternatives
TCR-T Library Phase 1/2 trial achieved an 87% disease control rate of eight evaluable patients with metastatic, refractory solid tumors; TCR-T cell therapy was well tolerated in all treated patientshu
No Data